EGFR and adenocarcinoma: Of interest, no BRAF mutations were found in lung adenocarcinomas that coexisted with BRAF-mutated AAH lesions, whereas four of five cases of BRAF-mutated AAH tumors coexisted with EGFR-mutated adenocarcinomas [75].